NCT05192031 is a NA clinical trial of Smoking cessation support in Suspected Lung Cancer, sponsored by Vejle Hospital.

Who is sponsoring NCT05192031?

NCT05192031 is sponsored by Vejle Hospital.

What drugs are being tested in NCT05192031?

Interventions in NCT05192031: Smoking cessation support.

What condition does NCT05192031 study?

NCT05192031 studies Suspected Lung Cancer.

Is NCT05192031 still recruiting?

NCT05192031 is currently active, enrolled. Last updated 1 April 2025.

Last reviewed 2025-04-01 · How we verify

NCT05192031

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of Smoking Cessation Support During Lung Cancer Workup

Active, enrolled NA Last updated 1 April 2025

What this trial tests

NA trial testing Smoking cessation support in Suspected Lung Cancer in 295 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

9 March 2022

Primary endpoint
1 March 2025

31 December 2025

Quick facts

Lead sponsor	Vejle Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	295
Start date	9 March 2022
Primary completion	1 March 2025
Estimated completion	31 December 2025
Sites	1 location across Denmark

Drugs / interventions tested

Smoking cessation support

Conditions studied

Suspected Lung Cancer — all drugs for Suspected Lung Cancer →

Sponsor

Vejle Hospital

Who can join

18 and older, any sex, with Suspected Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present project is to implement smoking cessation support in hospital-based lung cancer workup. The effect on 1) patients' smoking cessation attempts, motivation, quality of life and psychosocial consequences of lung cancer workup as well as 2) hospitals' number of referrals to municipality-based smoking cessation programmes will be evaluated in a pragmatic, cluster-randomised controlled setup, where participating hospitals will be assigned to the intervention arm (implementation of smoking cessation support) or the control arm (usual practice). Patients' and healthcare professionals' experiences with and barriers towards smoking cessation support will be explored in an interview-based, qualitative study.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for smoking cessation in hospitalised patients.
Streck JM, Rigotti NA, Livingstone-Banks J, Tindle HA, et al · · 2024 · cited 18× · PMID 38770804 · DOI 10.1002/14651858.cd001837.pub4
Integrating smoking cessation support during lung cancer diagnostic workup: a pragmatic, multicenter, cluster-randomised controlled trial.
Farver-Vestergaard I, Wellnitz KB, Hilberg O, Borg M, et al · · 2025 · PMID 41445708 · DOI 10.3389/frhs.2025.1696454

Verify or expand the search:

Other Vejle Hospital trials

Trials by the same sponsor.

NCT05776381 — The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp · Phase 2 · not yet recruiting
NCT07281820 — FRAME - Implementation of a PRO Measure to Inform Patient-Centered Survivorship Care in Oncology Outpatient Visits · NA · recruiting
NCT07511881 — Far-UVC and Infections in Long-term Care Facilities · NA · completed
NCT06279143 — The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes · recruiting
NCT06240078 — Impact of COPD on Sexual Health, Loneliness, and Well-being · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05192031 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vejle Hospital
Last refreshed: 1 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05192031.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing